Here’s a quick biology lesson on semaglutide’s mechanisms of action (stick with us — we ... the manufacturer of the diabetes and weight loss drugs Mounjaro® and Zepbound®.

FAT jabs like Mounjaro and Wegovy could slash boozing by two-thirds, a study has shown. It’s not the first time the weight ...

The filmmaker’s candid post opens a conversation about health, stigma, and promising advances in diabetes and weight ...

Already developing a trio of incretin drugs for obesity, Eli Lilly has its sights set on a candidate with a different mechanism of action that ... s GLP-1 agonist semaglutide in overweight and ...

Leveraging on its long-standing experience in liver and metabolic diseases, Galmed plans to advance the novel combination oncology program in parallel to the recently announced Semaglutide GLP-1 ...

This dual action ... 2 diabetes patients. While these advancements are encouraging, the complexity of the gut microbiome and its interactions with host metabolism necessitate further investigation.

Understand how semaglutide shows strong benefits in MASH treatment, improving liver health and reducing weight.

Participants who took tirzepatide (Zepbound) dropped an average of 50 pounds over 72 weeks. Those who took semaglutide ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...